Abstract:Increasing evidence has suggested that paracrine mechanisms might be involved in the underlying mechanism of mesenchymal stem cells (MSCs) transplantation, and exosomes are an important component of this paracrine role. However, MSCs are usually exposed to normoxia (21% O2) in vitro but experience large differences in oxygen concentration in the body under hypoxia. Indeed, hypoxic precondition of MSCs can enhance their paracrine effects. The main purpose of this study was to determine whether exosomes derived from MSCs under hypoxia (Hypo-Exos) exhibit greater effects on bone fracture healing than those under normoxia (Exos). Using in vivo bone fracture model and in vitro experiments including cell proliferation assay, cell migration assay and so on, we confirmed that Hypo-Exos administration promoted angiogenesis, proliferation and migration to a greater extent when compared to Exos. Furthermore, utilizing a series in vitro and in vivo gain and loss of function experiments, we confirmed a functional role for exosomal miR-126 in the process of bone fracture healing. Meanwhile, we found that knockdown of hypoxia inducible factor 1 (HIF-1α) resulted in a significant decrease of miR-126 in MSCs and exosomes, thereby abolishing the effects of Hypo-Exos. In conclusion, our results demonstrated a mechanism by which Hypo-Exos promote bone fracture healing through exosomal miR-126. Moreover, hypoxia preconditioning mediated enhanced production of exosomal miR-126 through the activation of HIF-1α. Hypoxia preconditioning represents an effective and promising method for the optimization of the therapeutic actions of MSC-derived exosomes for bone fracture healing.Statement of significanceStudies have confirmed that transplantation of exosomes exhibit similar therapeutic effects and functional properties to directly-transplanted stem cells but have less significant adverse effects. However, during in vitro culture conditions, MSCs are usually exposed to normoxia (21% O2) which is very different to the oxygen concentrations found in the body under natural physiological conditions. Our results demonstrated a mechanism by which Hypo-Exos promote bone fracture healing through exosomal miR-126 and the SPRED1/Ras/Erk signaling pathway. Moreover, hypoxia preconditioning mediated enhanced production of exosomal miR-126 through the activation of HIF-1α. Hypoxia preconditioning represents an effective and promising method for the optimization of the therapeutic actions of MSC-derived exosomes for bone fracture healing.

HIF-1α-induced Microrna-210 Reduces Hypoxia-Induced Osteoblast MG-63 Cell Apoptosis

Hypoxia-Induced MicroRNA-429 Promotes Differentiation of MC3T3-E1 Osteoblastic Cells by Mediating ZFPM2 Expression

MicroRNA-495 downregulates AQP1 and facilitates proliferation and differentiation of osteoblasts in mice with tibial fracture through activation of p38 MAPK signaling pathway

Inhibition of HIF-1α Restrains Fracture Healing Via Regulation of Autophagy in a Rat Model.

Hypoxia Promotes AMP-activated Protein Kinase (AMPK) and Induces Apoptosis in Mouse Osteoblasts.

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

MicroRNA-185 Inhibits the Growth and Proliferation of Osteoblasts in Fracture Healing by Targeting PTH Gene Through Down-Regulating Wnt/β -Catenin Axis: in an Animal Experiment.

microRNA-210 is involved in the regulation of postmenopausal osteoporosis through promotion of VEGF expression and osteoblast differentiation

mir-21 Overexpressing Mesenchymal Stem Cells Accelerate Fracture Healing in a Rat Closed Femur Fracture Model

MiR-140-5p Promotes Osteogenic Differentiation of Mouse Embryonic Bone Marrow Mesenchymal Stem Cells and Post-Fracture Healing of Mice

Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro.

IL‐10 induces MC3T3‐E1 cells differentiation towards osteoblastic fate in murine model

miR-210 Protects Renal Cell Against Hypoxia-induced Apoptosis by Targeting HIF-1 Alpha

Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126

Osteoclast-derived Exosomal Mir-214-3p Inhibits Osteoblastic Bone Formation.

Microrna-206 induces hypoxic necrosis of femoral head by inhibiting VEGF/PI3K/AKT signaling pathway

MicroRNA-139-3p regulates osteoblast differentiation and apoptosis by targeting ELK1 and interacting with long noncoding RNA ODSM

MicroRNA-874 Targeting SUFU Involves in Osteoblast Proliferation and Differentiation in Osteoporosis Rats Through the Hedgehog Signaling Pathway.

MiR‐148a regulates bone marrow mesenchymal stem cells‐mediated fracture healing by targeting insulin‐like growth factor 1

HIF-1α protects osteoblasts from ROS-induced apoptosis

Microrna-324-3p Promotes Osteoblasts Differentiation Via Suppressing SMAD7